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While the I kappa kinase (IKK) scaffolding protein
NF-kB essential modulator (NEMO) binds to polyubi-
quitin chains to transmit inflammatory signals, NEMO
itself is also ubiquitinated in response to a variety of
inflammatory agonists. Although there have been
hints that polyubiquitination of NEMO is essential
for avoiding inflammatory disorders, the in vivo phys-
iologic role of NEMO ubiquitination is unknown. In
this work, we knock in a NEMO allele in which two
major inflammatory agonist-induced ubiquitination
sites cannot be ubiquitinated. We show that mice
with a nonubiquitinatable NEMO allele display em-
bryonic lethality. Heterozygous females develop in-
flammatory skin lesions, decreased B cell numbers,
and hypercellular spleens. Embryonic lethality can
be complemented by mating onto a TNFR1/ back-
ground, at the cost of severe steatohepatitis and
early mortality, and we also show that NEMO ubiqui-
tination is required for optimal innate immune
signaling responses. These findings suggest that
NEMO ubiquitination is crucial for NF-kB activity in
response to innate immune agonists.
INTRODUCTION
Nontraditional ubiquitination plays a critical role in innate
immune signaling, and in no innate immune signaling pathway
is this better described than in the NF-kB pathway. In response
to a variety of inflammatory agonists, E3 ubiquitin ligases such as
TRAF2, TRAF6, cIAP1/2, and LUBAC are activated and induce
both K63-linked and linear ubiquitination of key signaling pro-
teins such as RIP1, RIP2, TAK1, and NF-kB essential modulator
(NEMO). These polyubiquitin chains then serve as binding sur-
faces to link signal transduction proteins and initiate and sustain
an NF-kB response. This theme is repeated across multiple
signaling pathways that culminate in NF-kB activation, including352 Cell Reports 4, 352–361, July 25, 2013 ª2013 The Authorsthe tumor necrosis factor (TNF), Toll-like receptor (TLR), and
nucleotide oligomerization domain (NOD) signaling pathways,
and is required for physiologic inflammation and the avoidance
of autoinflammatory disease (all reviewed in Chen, 2012, and
Hayden and Ghosh, 2012). Ultimately, these ubiquitin signaling
cascades converge upon the I kappa kinase (IKK) signalosome,
which in its most rudimentary form consists of IKKa and IKKb
both bound to the scaffolding protein NEMO. Within this central
NF-kB signaling hub, NEMO binds ubiquitin directly. It binds
both lysine 63 (K63)-linked and linear ubiquitin chains to allow
activation of the IKKs and NF-kB nuclear translocation with sub-
sequent gene expression (Wu et al., 2006; Cordier et al., 2009;
Laplantine et al., 2009; Lo et al., 2009; Rahighi et al., 2009,
Hadian et al., 2011; Ikeda et al., 2011; Kensche et al., 2012).
Lost in the fact that NEMO’s ubiquitin binding is a central
feature of inflammatory signal coordination is that NEMO itself
is both K63 and linearly polyubiquitinated (Abbott et al., 2004,
Zhou et al., 2004, Tokunaga et al., 2009). In a prominent, dis-
ease-related example, activation of the Crohn’s disease suscep-
tibility protein, NOD2, causes ubiquitination of NEMO at lysine
285 (K285). Loss-of-function Crohn’s-disease-associated poly-
morphisms do not allow this ubiquitination to occur, and this
loss of ubiquitination correlates with a substantial decrease in
NF-kB signaling in response to NOD2 activation (Abbott et al.,
2004, 2007; reviewed in Chen et al., 2009). While NOD2 allows
recognition of intracellular bacterial invasion by sensing a
breakdown product of peptidoglycan called muramyl dipeptide
(MDP) (Girardin et al., 2003; Inohara et al., 2003), extracellular
innate immune sensors also require NEMO ubiquitination for
signaling. Lipopolysaccharide (LPS) induces ubiquitination of
NEMO at a site presumed to be K399, and if this major LPS-
induced NEMO ubiquitination site is mutated in vivo, mice fail
to achieve a productive cytokine response and become hyper-
resistant in LPS-sepsis models (Ni et al., 2008). Thus, although
NEMO’s ubiquitin-binding capabilities have received much
more attention, its own ubiquitination appears to be equally
important for optimal NF-kB signaling in response to inflamma-
tory agonists.
Like K399 ubiquitination on NEMO, NEMO ubiquitination at
K285 also appears to be crucial for innate immune responses
(Abbott et al., 2004; Belgnaoui et al., 2012; Hinz et al., 2010; Kim
et al., 2011; Niu et al., 2011). It is required for effective viral re-
sponses in tissue culture systems (Zhao et al., 2007; Belgnaoui
et al., 2012), and work in our laboratory has shown that in both
tissue culture and reconstitution systems, K285 ubiquitination
is crucial for NOD2 signaling (Abbott et al., 2004, 2007). To
date, though, although a major innate immune ubiquitination
site (mouse K392, human K399) has been mutated in the whole
mouse (Ni et al., 2008), the othermajor innate immune ubiquitina-
tion site, K285, has not been mutated in vivo. Although K285
ubiquitination is crucial for NOD2 signaling in vitro and is thus
suggested to be important in pathophysiologic disease states
in which NOD2 signaling is dysregulated, its role in NOD2
signaling in nonoverexpression/reconstitution systems remains
speculative. The physiologic effect of this key NEMO ubiquitina-
tion site is unknown, and the consequence of the combined lack
of ubiquitination of these twomajor innate immune ubiquitination
sites is unknown.
Given the questions surrounding NEMO ubiquitination, we
generated a mouse that contained a humanized NEMO comple-
mentary DNA (cDNA) with K285 and K399 mutated to arginines.
In previous tissue culture studies, we found that NEMO with this
K285RK399R mutation could bind to the IKKs normally, but
could not signal properly in reconstituted MEF experiments
(Abbott et al., 2007). In the current in vivo study, we found that
the lack of ubiquitination on K285 and K399 caused embryonic
lethality in mice. Heterozygous knockin mice developed severe
skin ulcerations and inflammation that correlated with enlarged
spleens, decreased splenic B cells, and increased splenic
Gr1
+CD11b
+ cells. This embryonic lethality and inflammatory
phenotype can be genetically complemented by mating these
mice with TNFR1/ null mice, suggesting a genetic interaction
between the TNF pathway and NEMO ubiquitination. Despite
the fact that nonubiquitinatable NEMO no longer caused embry-
onic lethality, the TNFR1/XNemoKiY mice showed increased
mortality and evidence of severe steatohepatitis. Lastly, the
TNFR1/XNemoKiY mice were severely defective in NOD2,
TLR4, and interleukin-1 (IL-1) signaling, suggesting that ubiquiti-
nation of NEMO is essential for optimal innate immune-induced
cytokine production. In sum, this work provides evidence that
ubiquitination of NEMO is essential for proper functioning of
the NF-kB pathway, as the lack of ubiquitinated NEMO largely
phenocopies NEMO null mice. It also provides evidence of
complementarity of TNF signaling with NEMO ubiquitination
and establishes the in vivo role of NEMO ubiquitination in innate
immune signaling. Thus, while NEMO has received much atten-
tion for its role as a ubiquitin-binding protein, its own ubiquitina-
tion is also crucial for NF-kB function.
RESULTS
To determine the in vivo role of two major innate immune NEMO
ubiquitination sites, we generated a targeting construct that con-
tained amyc-tagged human NEMO cDNA containing lysines 285
and 399 mutated to arginine. In our previous studies we found
that this N-terminally myc-tagged mutant NEMO bound the
IKKs identically to untagged NEMO, and myc-tagged wild-type
(WT) NEMO was able to reconstitute NF-kB signaling in NEMOnull MEFs identically to untagged NEMO (Abbott et al., 2004,
2007). This cDNA was knocked into the endogenous NEMO
locus on the X chromosome such that it replaced exons 2–5 (Fig-
ure 1A). After establishing germline transmission, we mated the
NEMO knockin mice with flippase (FLP) recombinase mice to re-
move the NEO cassette, and then backcrossed them ten times
onto C57BL/6 to establish the XWTXNemoKi line. Evidence of pro-
tein expression (both with NEMO antibodies and via the myc tag)
and germline transmission is shown in Figure 1B. Matings aimed
at generating male NEMO knockin mice showed that, even
though >200 mice were generated, none were XNemoKiY sug-
gesting embryonic lethality (Figure 1C). The female heterozygous
mice displayed difficult fecundancy, as times between litters var-
ied between 27 and 90 days and did not display consistency
within a single mother or across mothers.
In addition to fertility difficulties, female heterozygous mice
developed ulcerating skin lesions (Figure 2A). Histologically,
these lesions showed hyperkeratosis and parakeratosis with
elongated rete ridges (Figure 2A) suggestive of a psoriasis-like
histology. Quantitative RT-PCR (qRT-PCR) analysis of lesional
skin showed elevated cytokines in the heterozygous NEMO
knockin mice compared with WT littermate controls (Figure 2B).
This skin inflammation correlated with the appearance of a
greatly enlarged spleen (Figure 2C). Quantitatively, the splenic
enlargement was due to an abundance of Gr1+CD11b+ cells
(Figure 2C), suggesting an inflammatory phenotype in these
mice. Splenic T cell counts were similar betweenWT and hetero-
zygous NEMO knockin mice, whereas splenic B cells were
decreased in the NEMO knockin mice (Figure 3). These findings
are consistent with the requirement for functional NEMO in B cell
development (Kim et al., 2003; Derudder et al., 2009). The results
obtained in the heterozygous NEMO knockin female mice
closely resemble those obtained in the heterozygous NEMO
knockout female mice. These heterozygous complete knockout
mice develop alopecia and inflammatory skin lesions, albeit in a
much more severe manner and at a much earlier age (Makris
et al., 2000; Rudolph et al., 2000; Schmidt-Supprian et al.,
2000). This fact, coupled with the embryonic lethality seen with
both a null allele and the K285RK399R allele, suggests that the
K285RK399R NEMO knockin allele is a loss-of-function allele,
and that after the loss of these two ubiquitination sites, it resem-
bles a null NEMO allele.
Due to the reproductive difficulties in the heterozygous NEMO
knockin mice, and because X inactivation essentially causes
chimerism in the heterozygous NEMO knockin mice, instead of
performing timed matings in a line with extremely irregular
estrous and birth cycles, we took an alternative approach to
determine the cause of embryonic lethality. NEMO null mice
die at E12–E13 because of massive liver apoptosis due to an
imbalance in TNF signaling favoring JNK-mediated apoptosis
over NF-kB-induced survival (Makris et al., 2000; Rudolph
et al., 2000; Schmidt-Supprian et al., 2000). Therefore, we
sought to determine whether TNF receptor (TNFR) loss would
complement the embryonic lethality in the NEMO knockin
mice. To this end, we mated TNFR1/ mice to the TNFR1/
heterozygous NEMO knockin mice to generate TNFR1/
XNemoKiY mice. Although these mice were generated at
less-than-Mendelian ratios, TNFR1/XNemoKiY were viable,Cell Reports 4, 352–361, July 25, 2013 ª2013 The Authors 353
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Figure 1. Knockin of a Nonubiquitinatable NEMO Allele Causes Embryonic Lethality
(A) Schematic of the targeting construct used to generate a nonubiquitinatable NEMO mouse. Exons 2–5 were replaced with a cDNA encoding NEMO in which
lysines 285 and 399were replaced with arginines such that ubiquitination could not occur. The construct was tagged on the N terminus with amyc tag such that it
could be differentiated from endogenous NEMO. Additionally, the NEO cassette was flanked by FRT sites such that when it was generated, the mouse could be
mated with a Flippase mouse to remove the NEO cassette.
(B) Stably transfected ES clones were assayed for nonubiquitinatable NEMO expression. An anti-myc western blot showed expression of the nonubiquitinatable
myc gene, and an anti-NEMO blot showed relative expression of endogenous knocked-in NEMO in the ESCs (upper panels). The lower panel shows germline
transmission in heterozygous female mice.
(C) Mendelian ratios of matings of WT male BL/6 mice with heterozygous female NEMO knockin mice. NEMO is on the X chromosome, and no NEMO knockin
males were observed in the >200 mice generated.suggesting that TNFR1 loss can complement the nonubiquitinat-
able NEMO phenotype (Figure 4A). Both the skin lesions and
hypercellularity of the spleens were not present in the
TNFR/XNemoKiY mice, further suggesting that TNF signaling
is responsible for the skin inflammation in the XWTXNemoKi mice,
and consistent with the results showing that the skin defect in
NEMO null mice can be reversed by mating onto a TNFR1 null
background (Nenci et al., 2006). The TNFR1/XNemoKiY were
not entirely healthy, however, as they showed increased mortal-
ity relative to either WT or TNFR1/ mice (Figure 4B). Whole
necropsy showed normal development and histology of organs,
with the exception of a substantially diseased liver. Histologi-354 Cell Reports 4, 352–361, July 25, 2013 ª2013 The Authorscally, the liver showed evidence of macro- and microvesicular
steatosis with centrilobular and zone 3 hepatitis, moderate
fibrosis, and regenerative nodules (Figure 4C). Hepatocytes
showeddysplasia with prominent nucleolar vacuoles (Figure 4C).
Liver function tests showed greatly elevated aspartate trans-
ferase (AST), alanine transferase (ALT), lactate dehydrogenase
(LDH), and total bilirubin, suggesting hepatocyte cell death and
acute hepatitis (Figure 4D). Together, these features closely
resemble those of nonalcoholic steatohepatitis (NASH) and the
phenotype of the hepatocyte-specific NEMO knockout mouse
(Beraza et al., 2007, 2009; Luedde et al., 2007), again suggesting
that the nonubiquitinatable NEMO is a loss-of-function allele.
A C
B
Figure 2. Nonubiquitinatable NEMO Knockin Mice Develop Inflammatory Skin Lesions and Splenomegaly
(A) Gross photograph of a representative 8-month-old nonubiquitinatable NEMO heterozygous female compared with a WT mouse. The nonubiquitinatable
NEMO heterozygous mice develop ulcerated and plaque-like lesions distributed throughout the body. Histologically, the plaque-like skin lesions show hyper-
keratosis, parakeratosis, keratin pearls, and a hyperproliferative epidermis with rete-ridge-like protrusions into the dermis. Nonlesional skin from the non-
ubiquitinatable heterozygous NEMO knockin mice shows little histological change relative to WT mice.
(B) qRT-PCR analysis of cytokines from the skin of WT littermates or from lesional or nonlesional skin from heterozygote nonubiquitinatable NEMO knockin
mice (n = 3). Cytokines are significantly elevated in both the lesional and nonlesional skin from the nonubiquitinatable NEMO heterozygous mice. SEM, *p < 0.05,
***p < 0.001.
(C) Representative gross picture showing the enlarged spleens present in the heterozygous nonubiquitinatable NEMO female mice relative to WT female
littermate control mice. Flow-cytometry gating on the different subsets of splenic immune cells reveals that the percentage of Gr1
+CD11b
+ cells is greatly
increased, suggesting an inflammatory phenotype in the heterozygous nonubiquitinatable NEMO mice.The generation of TNFR1/XNemoKiY mice also allowed us to
determine the role that ubiquitination of NEMOplays in the NOD2
signaling pathway. Our previous biochemical mapping and
signaling work was done in overexpression and reconstitution
systems (Abbott et al., 2004, 2007), and the role that NEMOubiq-
uitination plays in NOD2 signaling in vivo has been unclear. The
generation of this mouse allowed us to test the role of K285 and
K399 ubiquitination in NOD2-driven innate immune signaling. To
that end, we generated bone-marrow-derived macrophages
(BMDMs) from WT, TNFR1/, and TNFR1/XNemoKiY miceand treated them with the NOD2 agonist, MDP. Time courses
showed that while p38 signaling was intact, MDP-induced
NF-kB signaling and extracellular signal-regulated kinase
(ERK) signaling were greatly diminished (Figure 5A). Because
ERK signaling requires the IKKs to phosphorylate p105 (Yang
et al., 2012), these features suggest a proximal defect at the
level of the IKK signalosome. Importantly, NOD2 induction of
NEMO ubiquitination was lost in the BMDMs derived from
the TNFR1/XNemoKiY mice (Figure 5B), whereas binding to
the IKKs was retained (Figure S1). This suggests that theCell Reports 4, 352–361, July 25, 2013 ª2013 The Authors 355
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Figure 3. Normal T Cell Numbers but Decreased B Cell Numbers in the Spleens of XWTXNemoKi Mice
(A) Flow cytometry with CD3 and CD19 antibodies shows that whereas CD19CD3+ cells (T cells) are similar in number, C19+CD3 (B cells) are greatly diminished
in the XWTXNemoKi mice.
(B) Graphical representation of the fluorescent intensity of CD19 and CD3 staining, again showing diminished B cells in the XWTXNemoKi mice.
(C) Absolute number of splenic B and T cells in the WT and XWTXNemoKi mice. Similar results were found in a total of three mice from each genotype.replacement of these two lysine residues specifically affects
ubiquitination but leaves the general folding of NEMO intact.
To further verify this signaling defect, we performed qRT-PCR
of genes induced by MDP in these BMDMs. In all cases, the
TNFR1/XNemoKiY BMDMs showed greatly decreased MDP-
induced gene expression when stimulated by MDP (Figure 5C).
In sum, these features suggest a broad defect in NOD2 signaling
when NEMO cannot be ubiquitinated, and suggest that NEMO
ubiquitination is central to NOD2 signaling.
To further determine the role that NEMO ubiquitination plays
in generating and propagating innate immune signaling, we
stimulated TNFR1/XNemoKiY BMDMs with ultrapure LPS.
Although the initial levels IkBa decreased similarly (see lanes
2 and 7 in Figure 6A), BMDMs from TNFR1/XNemoKiY were
not able to sustain an NF-kB response, as indicated by their
inability to generate phosphorylated IkBa at later time points
of stimulation (Figure 6A). This was recapitulated by a marked
inability to generate LPS-driven cytokines (Figure 6B). Lastly,
the ability of two additional innate immune stimuli to generate
cytokine responses in these macrophages was determined.
Limiting doses of IL-1 showed a defect in cytokine release
(Figure 6C), whereas interferon g (IFNg) showed no specific
defect (Figure 6D). This last point is an important control. Cyto-
kine responses to IFNg are dependent on JAK-STAT pathways
and less so on NF-kB (Stark and Darnell, 2012). The fact that the
IFNg response is intact suggests that there is no broad immu-
nologic signaling defect in these cells. Collectively, these find-356 Cell Reports 4, 352–361, July 25, 2013 ª2013 The Authorsings suggest that NEMO ubiquitination is crucial for NF-kB-
directed cytokine responses.
DISCUSSION
Altogether, these findings highlight the importance of NEMO
ubiquitination in NF-kB signaling. Genetically, NEMO ubiquitina-
tion is required for a functioning IKK signalosome, as evidenced
by the fact that a NEMO allele that lacks the ability to be ubiqui-
tinated at K285 and K399 largely phenocopies NEMO loss. Both
NEMO null and NEMO K285RK399R mice show embryonic
lethality due to TNF signaling, and in the female heterozygous
state, both develop inflammatory skin lesions (Makris et al.,
2000; Rudolph et al., 2000; Schmidt-Supprian et al., 2000).
Thus, in addition to helping to coordinate NF-kB signaling
through the binding of ubiquitinated proteins, NEMO itself
must be ubiquitinated in order to function properly in the
NF-kB pathway. Failure to do so causes not only embryonic
lethality and steatohepatitis, but also dysfunction of a number
of innate immune signaling systems.
Productive inflammation is important not only for the body to
fight infection and damage, but also to avoid inflammatory dis-
ease. Because the NF-kB pathway represents one of the key in-
flammatorysignalingpathways in thebody, it is not surprising that
there are numerous checks and balances to optimize signaling.
One key point is that despite the fact that LPS-induced cytokine
release is significantly compromised in the TNFR1/XNemoKiY
A C
B
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Figure 4. Mating onto a TNFR1-Deficient Background Rescues Embryonic Lethality in Nonubiquitinatable NEMO Mice, but Causes
Steatohepatitis and Increased Mortality
(A) C57BL/6 TNFR1/ mice were mated with TNFR1+/+XWTXNemoKi mice and the resulting TNFR1+/XWTXNemoki mice were mated with TNFR1/XWTY mice to
obtain TNFR1/XWTXNemoKi mice, which were further mated with TNFR1/XWTY to generate TNFR1/XNemoKiY mice. The Mendelian ratios of this mating are
shown. In a WT TNFR1 background, we did not obtain pure NEMO knockin mice; however, when TNFR1 was deleted, we obtained male nonubiquitinatable
NEMO knockin mice, suggesting that TNFR1 deletion complements the nonubiquitinatable NEMO defect.
(B) Kaplan-Maier curves showing significantly decreased lifespans in the TNFR1/XNemoKiY and TNFR1/XNemoKiXNemoKi mice.
(C) Histologic evidence of steatohepatitis in the TNFR1/XNemoKiY mice, including macro- and microvesicular steatosis, inflammatory infiltrates most prominent
in zone 3 of the liver, and prominent nucleolar vacuolization (lower panel, nucleolar vacuolization is shown by arrows). These are all features of NASH.
(D) Elevated liver function tests in the TNFR1/XNemoKiY mice, indicating significant hepatocyte injury. SEM, *p < 0.05, **p < 0.01, ***p < 0.001.BMDMs, it is not completely abrogated. There is still a 10- to 20-
fold increase in cytokine release in these BMDMs (Figure 6B).
When compared with WT BMDMs, the increase is substantially
lower; however, it is still measurable. The same is true for MDP
and IL-1, albeit at a lower total induction level (Figures 5C and
6C). One interpretation of this finding is that the inability to induce
site-specific NEMO ubiquitination is not absolutely required for
signaling. It is only required for maximal signaling. Another inter-
pretation, suggested by the equivalent initial decrease in IkBa
levels upon LPS exposure with a failure to initiate a later wave
of phosphorylation of IkBa (Figure 6A), is that NEMO ubiquitina-
tion might be required to sustain NF-kB signaling.
An additional area of interest lies in the fact that TNFR loss
partially complements the NEMO knockin embryonic lethality.The NEMO knockin females’ fertility difficulties and irregular
breeding precluded us from determining the cause of the embry-
onic lethality; however, the fact that mating onto a TNFR1/
background complemented the lethality suggests that, like the
NEMO null mice, the NEMO knockin mice die of TNF-induced
liver apoptosis. This is interesting for two reasons. First, using re-
constituted NEMO null MEFs, we previously showed that NEMO
null cells reconstituted with K285R K399R NEMO via retroviral
transfer show intact TNF signaling (Abbott et al., 2007). The dif-
ferences between the in vitro system and the in vivo system
could be due to developmental timing, cell-type specificity, or
simple artifact due to overexpression. Second, the fact that
TNFR1 loss complements the embryonic lethality suggests a
genetic interaction. K399 ubiquitination was initially shown toCell Reports 4, 352–361, July 25, 2013 ª2013 The Authors 357
Figure 5. BMDMs Homozygous for Nonubiquitinatable NEMO Show a Severe Defect in NF-kB Signaling in Response to the NOD2
Agonist MDP
(A) Primary BMDMs were generated from TNFR1/XWTY, TNFR1/XNemoKiY, or TNFR1+/+XWTY mice and were treated with 10 mg/ml of MDP for the indicated
time period. BMDMs containing nonubiquitinatable NEMO showed an inability to phosphorylate two IKK substrates, IkBa and p105, in response to MDP. The
inability to phosphorylate p105 further leads to an inability to activate p44/p42 ERK in response to MDP.
(B) Primary BMDMs were generated from TNFR1/XWTY or TNFR1/XNemoKiY mice and were treated with 10 mg/ml of MDP for the indicated time period.
Lysates were generated in denaturing conditions (boiled with 1% SDS). After cooling, the SDS was diluted to 0.1% and NEMO immunoprecipitation was per-
formed. Western blotting showed that although WT NEMO could be inducibly ubiquitinated, knockin NEMO could not.
(C) To quantitate the signaling effect and to determine the role of NEMO ubiquitination in MDP-induced gene expression, the indicated BMDMswere treated with
10 mg/ml MDP for 4 hr before RNA was harvested and subjected to qRT-PCR. In all cases studied, the BMDMs expressing nonubiquitinatable NEMO showed
greatly decreased MDP-induced gene expression. SEM, *p < 0.05, **p < 0.01, ***p < 0.001.be TNF inducible by mutagenesis and reconstitution studies,
and was further shown to be required for optimal TNF-induced
NF-kB activity in tissue culture systems (Zhou et al., 2004). In
contrast, despite the fact that K285 has been shown repeatedly
to be directly ubiquitinated in mass spectrometry experiments
by numerous groups (Abbott et al., 2004; Hinz et al., 2010; Kim
et al., 2011; Niu et al., 2011), K285 ubiquitination has not yet
been linked in vivo to TNF signaling. Although a K285R-only
mouse has not been generated, the fact that the described
K399R (K391R mouse) does not show embryonic lethality,
coupled with the fact that the K285RK399R knockin mouse’s
embryonic lethality can be complemented by TNFR1 loss, im-
plies that K285 ubiquitination may be required for optimal TNF
family member signaling. Future work will address this possibility
both genetically and biochemically.
In summary, while ubiquitin chain binding by NEMO has been
shown to be important in physiologic NF-kB signaling, this work
shows that site-specific ubiquitination of NEMO is required for
physiologic NF-kB signaling as well.358 Cell Reports 4, 352–361, July 25, 2013 ª2013 The AuthorsEXPERIMENTAL PROCEDURES
Generation of NEMO Knockin Mice
NEMO knockin mice were generated under contract by Ingenious Targeting
Labs. The targeting vector shown in Figure 1A was designed to knock a
cDNA containing a full-length myc-tagged NEMO containing K285R and
K399R into exons 2–5 of the endogenous NEMO allele. After electroporation
into embryonic stem cells (ESCs; BA1 hybrid 129svev/C57Bl6N) and genera-
tion of stably integrated clones, as evidenced by both PCR and Southern blot-
ting, the ESCs were injected into C57Bl/6 blastocysts. Ten chimeric mice (six
males and four females) were derived. All six of the males showed 80%–90%
chimerism and two of the females showed 80%–90% chimerism. The chimeric
mice were mated and germline transmission of the knocked-in Nemo gene
was confirmed by PCR. These mice were twice backcrossed onto C57BL/6
FLT mice to excise the NEO cassette, and were further backcrossed onto
C57BL/6 eight additional times before experiments were performed.
TNFR1/ mice were obtained from The Jackson Laboratory.
Antibodies, Reagents, and Chemicals
Myc, NEMO (rbt), IKKa, IKKb, pIkBa, IkBa, phospho-ERK, ERK, phospho-
p105, phospho-p38, and p38 were obtained from Cell Signaling Technolo-
gies. Anti-Actin was obtained from Santa Cruz Biotechnologies. Anti-NEMO
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Figure 6. BMDMs Homozygous for Nonubiquitinatable NEMO Show Defects in TLR4 and IL-1 Responses but Normal IFN Responses
(A) Primary BMDMs were generated from TNFR1/XWTY, TNFR1/XNemoKiY, or TNFR1+/+XWTY mice and were treated with 25 ng/ml of LPS for the indicated
time period. Although the initial levels of total IkBa dropped in all three genetic lines, only BMDMs with WT NEMO could sustain an NF-kB response, as indicated
by phospho-IkBa and phospho-p105 blots. Erk signaling was likewise substantially diminished.
(B) To quantify and verify these signaling results, the indicated BMDMs were treated with LPS (3 ng/ml) for 4 hr. RNA was harvested and subjected to qRT-PCR.
Although all three genetic lines showed an increase in KC or TNF-a production, this was severely decreased in the BMDMs from TNFR1/XNemoKiY mice.
SEM, *p < 0.05, **p < 0.01.
(C) The indicated BMDMs were treated with IL-1 (5 ng/ml) for 4 hr before cells were harvested and subjected to qRT-PCR. IL-1-induced KC and IL-6 expression
was significantly impaired in the TNFR1/XNemoKiY BMDMs. SEM, *p < 0.05.
(D) The indicated BMDMs were treated with IFN-g (2 ng/ml) for 4 hr before cells were harvested and subjected to qRT-PCR. There were no significant changes in
gene expression between any of the cell lines. SEM.(monoclonal mouse clone C73-764) was obtained from BD Biosciences. MDP
was obtained from Bachem. Ultrapure LPS was obtained from InvivoGen. IL-1
was obtained from R&D Systems. All antibodies used in flow cytometry were
obtained from BioLegend.
BMDM Generation, Western Blotting, and Liver Function Tests
BMDMs from age- and sex-matched mice were generated by culturing BM
from the indicated mice for 7 days in 10% Dulbecco’s modified Eagle’s
medium (DMEM) with 25% conditioned Ladmac medium (a gift from Clifford
Harding, CWRU). The medium was changed to 10% fetal bovine serum
(FBS)-DMEM overnight before use. Western blotting was performed as previ-
ously described. Liver function tests were performed on whole blood at the
Mouse Physiology Core Facility of UC Davis.
Flow Cytometry
Spleens were harvested from mice 2 months of age. For each experiment,
age- and sex-matched mice were used. Splenocytes were resuspended in
RPMI with 10% serum and passed through a 70 mm cell strainer before centri-fugation at 1,200 rpm for 5 min. Red blood cells were lysed and cells were
adjusted to a concentration of 20 3 106 cells/ml; 50 ml of cells (1 3 106 cells)
were used for each staining condition. FcBlock was diluted according to the
recommended concentration and 25 ml was added to the cells for 5 min on
ice to block nonspecific binding. FcBlock, FITC anti-CD11b, APC anti-Gr1,
PE anti-CD11c, FITC anti-CD3, PE anti-CD19, FITC anti-CD4, PE anti-CD8,
and PE anti-Ly6G were all obtained from eBioscience. Antibody cocktails
were made fresh for each staining condition and 25 ml of cocktail was added
to the cells (for a total staining volume of 100 ml). Cells were stained for 1 hr
on ice, washed twice with PBS, and resuspended in 300 ml PBS. Data were
acquired using an A6 Accuri Flow cytometer (Invitrogen) and analyzed using
CFlow software (Invitrogen).
qRT-PCR and Statistical Analysis
RNA was isolated and reverse transcribed using a Quantitect RT kit (QIAGEN).
Primer sequences are listed in Tigno-Aranjuez et al. (2010). Sybr greenwas ob-
tained fromBio-Rad, and real-time PCRswere carried out with aCFX96 C1000
Real-Time Thermal Cycler from Bio-Rad. RT-PCR data are presented as theCell Reports 4, 352–361, July 25, 2013 ª2013 The Authors 359
mean ± SEM. RT-PCR experiments were performed in duplicate and repeated
twice. Results of representative experiments are shown. The significance of
the comparisons shown was assessed by Student’s two-tailed t test or a
chi-square test with the cutoff for significance set at p% 0.05.
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